Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - OtherShares OutstandingShares Outstanding
Ratios

Janux Therapeutics (JANX) Other Gross PP&E Adjustments (2020 - 2025)

Janux Therapeutics (JANX) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$13.4 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 1.98% to -$13.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13.4 million through Dec 2025, down 1.98% year-over-year, with the annual reading at -$13.4 million for FY2025, 1.98% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$13.4 million at Janux Therapeutics, down from -$8.1 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $2.7 million in Q1 2022, with the low at -$18.9 million in Q2 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$9.6 million, with a median of -$10.5 million recorded in 2024.
  • The sharpest move saw Other Gross PP&E Adjustments plummeted 20892.94% in 2022, then soared 34.95% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at $85000.0 in 2021, then tumbled by 20892.94% to -$17.7 million in 2022, then increased by 15.55% to -$14.9 million in 2023, then rose by 11.68% to -$13.2 million in 2024, then dropped by 1.98% to -$13.4 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$13.4 million, -$8.1 million, and -$7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.